市場調査レポート
商品コード
1073943
肺がん治療薬の世界市場規模:疾患タイプ別(非小細胞肺がん、小細胞肺がん)、治療法別、販売チャネル別、地域別の予測(2022年~2028年)Global Lung Cancer Therapeutics Market Size study, by Disease Type (Non-Small Cell Lung Cancer, Small Cell Lung Cancer ), by Therapy, by Sales Channel and Regional Forecasts 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
肺がん治療薬の世界市場規模:疾患タイプ別(非小細胞肺がん、小細胞肺がん)、治療法別、販売チャネル別、地域別の予測(2022年~2028年) |
出版日: 2022年05月06日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2~3営業日
|
世界の肺がん治療薬の市場規模は、2021年に約264億4,484万米ドルと評価され、予測期間である2022年~2028年には13%以上の健全な成長率で拡大すると予測されています。
工業化に伴う公害の増加、研究開発費の増加、肺がん罹患率の上昇が肺がん治療薬市場を牽引しています。また、研究の進展や整備された医療システムの開発が、肺がん治療薬の世界市場全体の成長を後押しする可能性が高いです。
しかし、肺がん治療薬の高コストが、2022年~2028年の予測期間にわたる市場の拡大を妨げる可能性があります。
当レポートでは、世界の肺がん治療薬市場を調査し、市場の概要、業界分析、COVID-19によるリスク評価、疾患タイプ別、治療法別、販売チャネル別、地域別の分析、および競合情報などを提供しています。
List of figures
Global Lung Cancer Therapeutics Market is valued at approximately USD 26444.84 Million in 2021 and is anticipated to grow with a healthy growth rate of more than 13 % over the forecast period 2022-2028. Lung cancer therapeutics comprise all the therapies to cure it. It is a fatal lung tumour characterised by uncontrolled cell proliferation in the lung tissues. The most significant risk factor for lung cancer is cigarette smoking. Lung cancer can also be caused by prolonged exposure to cigarette smoke. The diagnosis of lung cancer is verified by a biopsy performed under bronchoscopy or CT guidance. As a result, lung cancer can be treated using chemotherapy, radiation, immunotherapy, surgery, and other methods. Rising pollution due to Industrialization, increasing funding for Research & Development, and rising prevalence of Lung Cancer have driven the Lung Cancer Therapeutics Market. For Instance: As per the reports of the American Cancer Society, there will be 236,740 lung and bronchus cancer diagnoses and 130,180 deaths in the United States in 2022. About 85 percent of those cases are predicted to be NSCLC. Also, rising advancements in Research and development of a well-structured healthcare system are most likely to boost the overall growth of the Global Lung Cancer Therapeutics Market. However, high cost of Lung Cancer Therapeutics can obstruct the market's expansion over the projection period of 2022-2028.
The key regions considered for the global Lung Cancer Therapeutics Market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Rising development of a well-structured healthcare system and presence of major key players is driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 20222028. The market is expected to grow during the projected period, due to rising prevalence of Lung Cancer.
Major market players included in this report are:
Genentech Inc.
Eli Lillly and Company
Celgene Corporation
AstraZeneca
Pfizer Inc.
Sanofi Pharma
Novartis AG
Merck Sharp and Dohme Corp.
Millennium Pharmaceuticals Inc.
Astellas Pharma`2
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the Therapy within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disease Type:
Non-Small Cell Lung Cancer (NSCLC)
Small Cell Lung Cancer (SCLC))
By Therapy:
Targeted Therapy
Immunotherapy
Chemotherapy
By Sales Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Lung Cancer Therapeutics Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors